Intellia Therapeutics (NTLA) shares were down 6.1% in recent Monday trading after Morgan Stanley downgraded the company's stock to equal weight from overweight and cut its price target to $11 from $56.
The company's trading volume stood at 1.85 million shares against a daily average of 2.84 million.
Price: 10.32, Change: -0.67, Percent Change: -6.10